The Joint IRDiRC-RE(ACT) Congress | March 11-14, 2020
This joint event will continue the RE(ACT) Congress series (6th edition) and IRDiRC Conference series (4th edition). It aims to bring together scientific leaders and experts and young scientists from a variety of breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research. Patients and patient organizations, who are committed to research, will also be in attendance to share their experiences and perspectives.
Join a major event on rare diseases in 2020: The RE(ACT) Congress and IRDiRC Conference. When? March 11-14 2020. Where? Berlin, Germany.
Early bird registration has been extended until Friday Dec 20 2019 – https://www.react-congress.org/attendees/registration-2/
Young and professional scientists, patients & patient representatives, as well as other rare diseases stakeholders are welcome to discuss latest cutting-edge research, innovation, and policy with the leaders in the rare disease fields. You can consult the list of speakers here – https://www.react-congress.org/speakers/
The scientific program has been inspired by IRDiRC principles and achievements and by the IRDiRC activities foreseen in 2020 and it encompasses topics like diagnosis & artificial intelligence, molecular etiology, innovative clinical trials, patient engagement and drugs for all.
The full program is available here – https://www.react-congress.org/program/full-program/
For abstract information and submission here – https://www.react-congress.org/attendees/abstract-information/
The exceptional joint edition is being organized by the Blackswan Foundation –
and IRDiRC in collaboration with the European Joint Program on Rare Diseases (EJP RD) and in partnership with EURORDIS and the Rare Diseases
International (RDI, global alliance of people living with rare disease).